Pharmacoeconomic comparison of the second generation insulin analogs and insulins on their base
Effective control of Diabetes Mellitus (DM) is an actual task from clinical and economic points of view. The second generation insulin analogs increase level of DM compensation without hypoglycemia. The economic aspects of their usage have been evaluated early, but it is still actual due to changes...
Main Authors: | , |
---|---|
格式: | 文件 |
语言: | Russian |
出版: |
Izdatelstvo OKI
2021-04-01
|
丛编: | Качественная клиническая практика |
主题: | |
在线阅读: | https://www.clinvest.ru/jour/article/view/555 |